NCT01125761

Efficacy and Safety of the Association Drugs in Patients With Allergic Dermatitis

Efficacy and Safety of the Association of Dexamethasone 0.5 mg + Clemastine Fumarate 1 mg When Compared to Dexamethasone 0.5 mg in Patients With Allergic Dermatitis

• Status: Withdrawn
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Azidus Brasil · Industry
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Considering the pathogenesis of several allergic skin diseases to be investigated in this study as well as the pharmacodynamic mechanisms of the association of dexamethasone and clemastine fumarate, it is believed that the components of topical medication may act synergistically in the reduction of signs and symptoms of the diseases in question. Therefore it is expected that the association promotes results significantly superior to dexamethasone alone.

Conditions

• Dermatitis

Interventions

Type	Name	Description
DRUG	dexamethasone 0.5 mg and 1.0 mg clemastine cream	The treatment should be administered every 12 hours so that a thin layer is applied on the lesions, for 14 days.
DRUG	Dexamethasone 0,5 mg cream	The treatment should be administered every 12 hours so that a thin layer is applied on the lesions, for 14 days.

Timeline

• Start date: 2010-11-01
• Primary completion: 2010-11-01
• Completion: 2010-11-01
• First posted: 2010-05-18
• Last updated: 2022-11-03

Locations

2 sites across 1 country: Brazil